Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs Entrada Therapeutics
Over the past year BBOT returned −81.1% and TRDA returned −30.4%; their daily moves had a correlation of 0.20.
BBOT −81.1% TRDA −30.4%Growth of $1, one year, split-adjusted
| Metric | BBOT | TRDA |
|---|---|---|
| Price | $2.32 | $4.72 |
| Market cap | $186.0M | $183.8M |
| Today | +0.43% | −7.63% |
| 1 month | −35.6% | −13.9% |
| 6 months | −71.9% | −70.0% |
| Year to date | −81.5% | −54.1% |
| 1 year | −80.6% | −32.1% |
| Revenue growth (YoY) | — | −53.9% |
| Gross margin | — | 100.0% |
| Net margin | — | −4762.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 39.2× |
| Net cash | $225.7M | $223.0M |
| Dividend yield | — | — |
| Volatility (60d) | 87.9% | 84.9% |
| Short % of float | 13.9% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).